Literature DB >> 6450608

Severe aplastic anaemia: correlation of in vitro test with clinical response to immunosuppression in 20 patients.

A Bacigalupo, M Podesta', M T Van Lint, R Vimercati, R Cerri, E Rossi, M Risso, A Carella, G Santini, E Damasio, D Giordano, A M Marmont.   

Abstract

Colony formation in agar (CFU-c) was studied in 20 patients with severe aplastic anaemia by three different assays: (1) cultures of light density untreated marrow cells; (2) cultures of marrow cells manipulated in order to enhance colony formation (pretreatment with antilymphocytic globulin, ALG, or 6-methylprednisolone, 6-MPr, T cell depletion, adherent cell (AC) depletion, depletion of both AC and T cells), and (3) co-culture of putative suppressor T cells with autologous T-depleted marrow cells. By the first assay, all patients showed poor colony formation (1 +/- 1.5 colonies/10(5) cells; normal controls 46 +/- 18 colonies/10(5) cells). By the second assay, ALG and 6-MPr had no significant effect on colony formation. Removal of adherent cells proved equally without effect on colony growth. On the contrary, removal of T cells enhanced significantly (P less than 0.001) colony formation in 10 out of 20 patients. By the third assay, colony formation of marrow cells (deprived of T lymphocytes) was inhibited by the addition of autologous T cells in six patients studied. All patients were given high dose bolus 6-MPr as first treatment on admission: only patients who had detectable suppressor T cells in their marrow achieved a complete autologous haematologic reconstitution after 6-MPr or after 6-MPr and ALG. The results of this study indicate the detection of CFU-c/suppressor T cells correlates with responses to immunosuppressive regimens, and may thus help to identify patients with immune mediated aplastic anaemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450608     DOI: 10.1111/j.1365-2141.1981.tb02810.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin.

Authors:  N Frickhofen; W Heit; A Raghavachar; F Porzsolt; H Heimpel
Journal:  Klin Wochenschr       Date:  1986-11-17

2.  Immunosuppressive treatment of aplastic anemia: a prospective, randomized multicenter trial evaluating antilymphocyte globulin (ALG) versus ALG and cyclosporin A.

Authors:  N Frickhofen; J P Kaltwasser
Journal:  Blut       Date:  1988-04

3.  Pure red cell aplasia and thymoma associated with high levels of the suppressor/cytotoxic T lymphocyte subset.

Authors:  J P Milnes; B P Goorney; T B Wallington
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

Review 4.  In vitro evidence of drug action in aplastic anemia.

Authors:  P C Vincent
Journal:  Blut       Date:  1984-07

Review 5.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

6.  CFU-C inhibitors in aplastic anaemia.

Authors:  T C Morris; P C Vincent; G A Young; R Sutherland; P R Forrest; J P Isbister
Journal:  Blut       Date:  1984-02

7.  Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors.

Authors:  E C Gordon-Smith; S M Fairhead; P M Chipping; J Hows; D C James; A Dodi; J R Batchelor
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.